Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers. Page R, Patil D, Akolkar D, Murthy SS, et al. PLoS One 2022;17:e0270139.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Page R, Patil D, Akolkar D, Murthy SS, et al. Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers. PLoS One 2022;17:e0270139.
PMID: 35714131